MedTrace Logo

Renkli Adımlar Game- and Drama-Based Program for Preventing Peer Bullying in Primary School Children

NCT07696455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2026-07-10

No results posted yet for this study

Summary

This randomized controlled trial evaluated the effectiveness of the Renkli Adımlar (Colorful Steps) game- and drama-based school intervention in promoting empathy and reducing bullying perpetration and victimization among primary school children. Third- and fourth-grade students were allocated to an intervention or control group. The intervention consisted of eight weekly 40-minute sessions including educational games, creative drama, role-playing, storytelling, puppet activities, and collaborative learning. Empathy, bullying perpetration, and victimization were assessed before and immediately after the intervention using standardized instruments.

Conditions

  • Bullying
  • Victimisation

Interventions

BEHAVIORAL

Renkli Adımlar Game- and Drama-Based Program

The Renkli Adımlar (Colorful Steps) program is a researcher-developed, school-based intervention designed to prevent peer bullying and promote empathy among primary school children. The intervention was delivered over eight consecutive weeks, with one 40-minute session per week. The program incorporated educational games, creative drama, role-playing, storytelling, puppet activities, cooperative learning, and classroom discussions. The sessions addressed bullying awareness, emotion recognition, coping with bullying, positive peer communication, cyberbullying, and problem-solving skills.

Sponsors & Collaborators

  • Burdur Mehmet Akif Ersoy University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-02
Primary Completion
2026-03-30
Completion
2026-03-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07696455 on ClinicalTrials.gov